GHM Cardiac US Cardiac Markers Rapid Test (FIA) – Quantitative, 15-Minute, Whole Blood/Serum/Plasma

SKU: GHM Cardiac US
Brand: Global Healthcare Medical

Product Overview

Global Healthcare Medical GHM Cardiac US Cardiac Markers Rapid Test (FIA) is a fluorescence immunoassay (FIA) designed for the quantitative determination of cardiac biomarkers, including Cardiac Troponin I (cTnI), Creatine Kinase-MB (CK-MB), Myoglobin (MYO), Heart-type Fatty Acid Binding Protein (H-FABP), and N-terminal pro-B-type Natriuretic Peptide (NT-proBNP), in human whole blood, serum, or plasma samples. Measurements of these blood cardiac biomarkers may serve as indicators for diagnosis of myocardial injury secondary to cTnI and CK-MB, and can help assess the prognosis of patients. The system is also useful as an aid in the management and monitoring of acute myocardial infarction (AMI) and heart failure.

Cardiovascular disease (CVD) stands as the primary cause of global mortality, necessitating early diagnosis for mitigating death rates and improving quality of life. Point-of-care testing (POCT) enables immediate diagnosis at the patient's bedside, reducing hospital stays and improving early intervention. The cardiac biomarkers diagnostics industry is set for transformative growth, fueled by innovation in high-sensitivity assays, multiplex biomarker panels, and POCT advancements.

The GHM Cardiac US is intended for use with the FIA Analyzer (VIM01), a compact benchtop analyzer that utilizes fluorescence immunochromatography technology. The analyzer features auto calibration, barcode identification, and a built-in memory capacity of 50,000 results. The analyzer delivers reliable results in 10 ± 5 seconds after the test device is inserted.

The system is designed for professional use in clinical laboratories, hospitals, and clinics. The FIA analyzer operates with a small sample volume and provides fast, reliable results with simple operation.

This product is for in vitro diagnostic use only. For professional use only.

Key Features & Benefits

Quantitative Cardiac Biomarker Measurement – Aid in Myocardial Injury Assessment

The GHM Cardiac US delivers quantitative cardiac biomarker results, providing measurable concentration values that can be used as an aid in the diagnosis and management of acute myocardial infarction and other cardiac conditions. Cardiac troponin I and CK-MB are well-established biomarkers for myocardial injury, and their measurement supports timely clinical decision-making in acute care settings. The International Federation of Clinical Chemistry and Laboratory Medicine Committee on Clinical Application of Cardiac Bio-Markers (IFCC C-CB) has developed educational guidance on how high-sensitivity cardiac troponin point-of-care assays may be implemented in acute healthcare settings and networks.

Comprehensive Test Menu – Broad Cardiac Marker Coverage

The GHM Cardiac US supports detection of a comprehensive panel of cardiac biomarkers, providing broad coverage for clinical cardiovascular testing needs.

Clinical Applications by Marker:

Multiple panel configurations available. Contact Global Healthcare Medical for the complete test menu and panel customization options.

Sandwich Immunodetection Method – Fluorescence Immunoassay Principle

The GHM Cardiac US uses a sandwich immunodetection method. When the sample is added to the sample well of the test device, fluorescence-labeled detector antibodies bind to cardiac biomarker antigens in the sample. As the sample mixture migrates on the nitrocellulose matrix of the test strip by capillary action, the complexes of detector antibody and cardiac biomarker antigen are captured by immobilized capture antibodies at specific test lines on the strip. Thus, the more cardiac biomarker antigen in the specimen, the more complexes accumulate on the test strip. The signal intensity of the fluorescent signal reflects the amount of cardiac biomarker captured, and the FIA Analyzer displays the cardiac biomarker concentration in the specimen.

VivaDiag FIA Analyzer – Advanced Technical Platform

The GHM Cardiac US is used with the FIA Analyzer (VIM01), a compact fluorescence immunoassay analyzer featuring auto calibration, barcode identification, and a large memory capacity. The analyzer can detect 30+ parameters by auto-scanning the code chip.

Wide Storage Temperature – No Cold Chain Required

The test kit is designed for convenient storage and transport, with a storage temperature range of 2 ~ 30°C, eliminating the need for cold chain logistics.

Simple Operation – Professional Laboratory Testing

The test procedure involves three simple steps: mix the sample with buffer, add the mixed specimen, and insert the device into the analyzer.

Product Specifications

Why Clinical Laboratories Choose Global Healthcare Medical